Molecular Characterization of Gene-Mediated Resistance and Susceptibility of ESKAPE Clinical Isolates to Cistus monspeliensis L. and Cistus salviifolius L. Extracts

Background. Multidrug resistance (MDR) and extensively drug-resistant (XDR) are now the biggest threats to human beings. Alternative antimicrobial regimens to conventional antibiotic paradigms are extensively searched. Although Cistus extracts have long been used for infections in traditional folk m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Evidence-based complementary and alternative medicine 2022-09, Vol.2022, p.1-16
Hauptverfasser: Zalegh, Imane, Bourhia, Mohammed, Zerouali, Khalid, Katfy, Khalid, Nayme, Kaotar, Khallouki, Farid, Benzaarate, Ihssane, Mohammad Salamatullah, Ahmad, Alzahrani, Abdulhakeem, Nafidi, Hiba-Allah, Akssira, Mohamed, Ait Mhand, Rajaa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 16
container_issue
container_start_page 1
container_title Evidence-based complementary and alternative medicine
container_volume 2022
creator Zalegh, Imane
Bourhia, Mohammed
Zerouali, Khalid
Katfy, Khalid
Nayme, Kaotar
Khallouki, Farid
Benzaarate, Ihssane
Mohammad Salamatullah, Ahmad
Alzahrani, Abdulhakeem
Nafidi, Hiba-Allah
Akssira, Mohamed
Ait Mhand, Rajaa
description Background. Multidrug resistance (MDR) and extensively drug-resistant (XDR) are now the biggest threats to human beings. Alternative antimicrobial regimens to conventional antibiotic paradigms are extensively searched. Although Cistus extracts have long been used for infections in traditional folk medicines around the world, their efficacy against resistant bacteria still needs to be elucidated. We aim to investigate the antibiotic susceptibility profiles of clinical strains Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter cloacae (acronym “ESKAPE”), and their resistance mechanisms by PCR, as well as their sensitivity to C. monspeliensis (CM) and C. salviifolius (CS) methanol extracts and their fractions. Methods. Antibiotic susceptibility profile and resistance mechanism were done by antibiogram and PCR. Fractions of CM and CS were obtained using maceration and Soxhlet; their antibacterial activities were evaluated by determining inhibition zone diameter (IZD), minimum inhibitory concentration (MIC), and minimum bactericidal concentration (MBC). Results. Results revealed that all strains were XDR except S. aureus, which was MDR. The PCR indicates the presence of gene-mediated resistance (blaCTX-M, blaSHV, blaOXA-48, blaNDM, blaOXA-51, blaOXA-58, blaIMP, blaVIM, and blamecA). Also, maceration was slightly better for bioactivity preservation. Overall, the extracts of CM (IZD = 20 mm, MIC = 0.01 mg/mL) were more active than those of CS. All extracts inhibited MRSA (methicillin-resistant Staphylococcus aureus) and ERV (Enterococcus faecium Vancomycin-Resistant) with interesting MICs. The ethyl acetate fraction manifested great efficacy against all strains. Monoterpene hydrocarbons and sesquiterpenes oxygenated were the chemical classes of compounds dominating the analyzed fractions. Viridiflorol was the major compound in ethyl acetate fractions of 59.84% and 70.77% for CM and CS, respectively. Conclusions. The superior activity of extracts to conventional antibiotics was seen for the first time in the pathogens group, and their bactericidal effect could be a promising alternative for developing clinical antibacterial agents against MDR and XDR ESKAPE bacteria.
doi_str_mv 10.1155/2022/7467279
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9532067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2722976119</sourcerecordid><originalsourceid>FETCH-LOGICAL-c425t-f24f7657d3da4c9cce84a622ba11ceab8e13999dba0fd8736eb30833a57494c93</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhSMEEqVw4wdY4oIEaWM7iZMLUhUtpWIrEAWJmzVxJuxUXnuJnUL5PfxQnO6qEhw42dL73puxX5Y958UJ51V1KgohTlVZK6HaB9kRVyXPS9E0D-_v6uvj7EkI10UhWqXUUfb70ls0s4WJdRuYwESc6BdE8o75kZ2jw_wSB4KIA_uEgUIEZ5CBG9jVHAzuIvVkKd4u-Orq_dnHFessOTJg2UXwNjkDi551yToHtvUu7NASupTF1id3SQctgL0hGr2l-U5a_YzLRuFp9mgEG_DZ4TzOvrxdfe7e5esP5xfd2To3pahiPopyVHWlBjlAaVpjsCmhFqIHzg1C3yCXbdsOPRTj0ChZYy-LRkqoVNkmgzzO3uxzd3O_xcGgS_Ot3k20helWeyD9t-Joo7_5G91WUhS1SgEvDwGT_z5jiHpL6Y-sBYd-DlooIXmlRLXMevEPeu3nyaXnLVRqp-Z8oV7vKTP5ECYc75fhhV4610vn-tB5wl_t8Q25AX7Q_-k_PV-vVQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2722976119</pqid></control><display><type>article</type><title>Molecular Characterization of Gene-Mediated Resistance and Susceptibility of ESKAPE Clinical Isolates to Cistus monspeliensis L. and Cistus salviifolius L. Extracts</title><source>PubMed Central Open Access</source><source>Wiley-Blackwell Open Access Titles</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Zalegh, Imane ; Bourhia, Mohammed ; Zerouali, Khalid ; Katfy, Khalid ; Nayme, Kaotar ; Khallouki, Farid ; Benzaarate, Ihssane ; Mohammad Salamatullah, Ahmad ; Alzahrani, Abdulhakeem ; Nafidi, Hiba-Allah ; Akssira, Mohamed ; Ait Mhand, Rajaa</creator><contributor>Ramanathan, Srinivasan ; Srinivasan Ramanathan</contributor><creatorcontrib>Zalegh, Imane ; Bourhia, Mohammed ; Zerouali, Khalid ; Katfy, Khalid ; Nayme, Kaotar ; Khallouki, Farid ; Benzaarate, Ihssane ; Mohammad Salamatullah, Ahmad ; Alzahrani, Abdulhakeem ; Nafidi, Hiba-Allah ; Akssira, Mohamed ; Ait Mhand, Rajaa ; Ramanathan, Srinivasan ; Srinivasan Ramanathan</creatorcontrib><description>Background. Multidrug resistance (MDR) and extensively drug-resistant (XDR) are now the biggest threats to human beings. Alternative antimicrobial regimens to conventional antibiotic paradigms are extensively searched. Although Cistus extracts have long been used for infections in traditional folk medicines around the world, their efficacy against resistant bacteria still needs to be elucidated. We aim to investigate the antibiotic susceptibility profiles of clinical strains Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter cloacae (acronym “ESKAPE”), and their resistance mechanisms by PCR, as well as their sensitivity to C. monspeliensis (CM) and C. salviifolius (CS) methanol extracts and their fractions. Methods. Antibiotic susceptibility profile and resistance mechanism were done by antibiogram and PCR. Fractions of CM and CS were obtained using maceration and Soxhlet; their antibacterial activities were evaluated by determining inhibition zone diameter (IZD), minimum inhibitory concentration (MIC), and minimum bactericidal concentration (MBC). Results. Results revealed that all strains were XDR except S. aureus, which was MDR. The PCR indicates the presence of gene-mediated resistance (blaCTX-M, blaSHV, blaOXA-48, blaNDM, blaOXA-51, blaOXA-58, blaIMP, blaVIM, and blamecA). Also, maceration was slightly better for bioactivity preservation. Overall, the extracts of CM (IZD = 20 mm, MIC = 0.01 mg/mL) were more active than those of CS. All extracts inhibited MRSA (methicillin-resistant Staphylococcus aureus) and ERV (Enterococcus faecium Vancomycin-Resistant) with interesting MICs. The ethyl acetate fraction manifested great efficacy against all strains. Monoterpene hydrocarbons and sesquiterpenes oxygenated were the chemical classes of compounds dominating the analyzed fractions. Viridiflorol was the major compound in ethyl acetate fractions of 59.84% and 70.77% for CM and CS, respectively. Conclusions. The superior activity of extracts to conventional antibiotics was seen for the first time in the pathogens group, and their bactericidal effect could be a promising alternative for developing clinical antibacterial agents against MDR and XDR ESKAPE bacteria.</description><identifier>ISSN: 1741-427X</identifier><identifier>EISSN: 1741-4288</identifier><identifier>DOI: 10.1155/2022/7467279</identifier><language>eng</language><publisher>New York: Hindawi</publisher><subject>Acetic acid ; Antibacterial activity ; Antibacterial agents ; Antibiotics ; Antimicrobial agents ; Bacteria ; Bacterial infections ; Biological activity ; Cistus monspeliensis ; Cistus salviifolius ; Clinical isolates ; Developing countries ; Drug resistance ; Enterococcus faecium ; Ethyl acetate ; Genes ; Laboratories ; LDCs ; Methicillin ; Minimum inhibitory concentration ; Multidrug resistance ; Nosocomial infections ; Phytochemicals ; Sesquiterpenes ; Staphylococcus aureus ; Strains (organisms) ; Vancomycin ; Viridiflorol</subject><ispartof>Evidence-based complementary and alternative medicine, 2022-09, Vol.2022, p.1-16</ispartof><rights>Copyright © 2022 Imane Zalegh et al.</rights><rights>Copyright © 2022 Imane Zalegh et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2022 Imane Zalegh et al. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c425t-f24f7657d3da4c9cce84a622ba11ceab8e13999dba0fd8736eb30833a57494c93</citedby><cites>FETCH-LOGICAL-c425t-f24f7657d3da4c9cce84a622ba11ceab8e13999dba0fd8736eb30833a57494c93</cites><orcidid>0000-0003-4997-2348 ; 0000-0003-3707-8461 ; 0000-0001-8867-2837 ; 0000-0003-1473-0867 ; 0000-0003-1685-1400 ; 0000-0003-1390-8248 ; 0000-0002-6103-4269</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532067/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532067/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><contributor>Ramanathan, Srinivasan</contributor><contributor>Srinivasan Ramanathan</contributor><creatorcontrib>Zalegh, Imane</creatorcontrib><creatorcontrib>Bourhia, Mohammed</creatorcontrib><creatorcontrib>Zerouali, Khalid</creatorcontrib><creatorcontrib>Katfy, Khalid</creatorcontrib><creatorcontrib>Nayme, Kaotar</creatorcontrib><creatorcontrib>Khallouki, Farid</creatorcontrib><creatorcontrib>Benzaarate, Ihssane</creatorcontrib><creatorcontrib>Mohammad Salamatullah, Ahmad</creatorcontrib><creatorcontrib>Alzahrani, Abdulhakeem</creatorcontrib><creatorcontrib>Nafidi, Hiba-Allah</creatorcontrib><creatorcontrib>Akssira, Mohamed</creatorcontrib><creatorcontrib>Ait Mhand, Rajaa</creatorcontrib><title>Molecular Characterization of Gene-Mediated Resistance and Susceptibility of ESKAPE Clinical Isolates to Cistus monspeliensis L. and Cistus salviifolius L. Extracts</title><title>Evidence-based complementary and alternative medicine</title><description>Background. Multidrug resistance (MDR) and extensively drug-resistant (XDR) are now the biggest threats to human beings. Alternative antimicrobial regimens to conventional antibiotic paradigms are extensively searched. Although Cistus extracts have long been used for infections in traditional folk medicines around the world, their efficacy against resistant bacteria still needs to be elucidated. We aim to investigate the antibiotic susceptibility profiles of clinical strains Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter cloacae (acronym “ESKAPE”), and their resistance mechanisms by PCR, as well as their sensitivity to C. monspeliensis (CM) and C. salviifolius (CS) methanol extracts and their fractions. Methods. Antibiotic susceptibility profile and resistance mechanism were done by antibiogram and PCR. Fractions of CM and CS were obtained using maceration and Soxhlet; their antibacterial activities were evaluated by determining inhibition zone diameter (IZD), minimum inhibitory concentration (MIC), and minimum bactericidal concentration (MBC). Results. Results revealed that all strains were XDR except S. aureus, which was MDR. The PCR indicates the presence of gene-mediated resistance (blaCTX-M, blaSHV, blaOXA-48, blaNDM, blaOXA-51, blaOXA-58, blaIMP, blaVIM, and blamecA). Also, maceration was slightly better for bioactivity preservation. Overall, the extracts of CM (IZD = 20 mm, MIC = 0.01 mg/mL) were more active than those of CS. All extracts inhibited MRSA (methicillin-resistant Staphylococcus aureus) and ERV (Enterococcus faecium Vancomycin-Resistant) with interesting MICs. The ethyl acetate fraction manifested great efficacy against all strains. Monoterpene hydrocarbons and sesquiterpenes oxygenated were the chemical classes of compounds dominating the analyzed fractions. Viridiflorol was the major compound in ethyl acetate fractions of 59.84% and 70.77% for CM and CS, respectively. Conclusions. The superior activity of extracts to conventional antibiotics was seen for the first time in the pathogens group, and their bactericidal effect could be a promising alternative for developing clinical antibacterial agents against MDR and XDR ESKAPE bacteria.</description><subject>Acetic acid</subject><subject>Antibacterial activity</subject><subject>Antibacterial agents</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Bacteria</subject><subject>Bacterial infections</subject><subject>Biological activity</subject><subject>Cistus monspeliensis</subject><subject>Cistus salviifolius</subject><subject>Clinical isolates</subject><subject>Developing countries</subject><subject>Drug resistance</subject><subject>Enterococcus faecium</subject><subject>Ethyl acetate</subject><subject>Genes</subject><subject>Laboratories</subject><subject>LDCs</subject><subject>Methicillin</subject><subject>Minimum inhibitory concentration</subject><subject>Multidrug resistance</subject><subject>Nosocomial infections</subject><subject>Phytochemicals</subject><subject>Sesquiterpenes</subject><subject>Staphylococcus aureus</subject><subject>Strains (organisms)</subject><subject>Vancomycin</subject><subject>Viridiflorol</subject><issn>1741-427X</issn><issn>1741-4288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kUFv1DAQhSMEEqVw4wdY4oIEaWM7iZMLUhUtpWIrEAWJmzVxJuxUXnuJnUL5PfxQnO6qEhw42dL73puxX5Y958UJ51V1KgohTlVZK6HaB9kRVyXPS9E0D-_v6uvj7EkI10UhWqXUUfb70ls0s4WJdRuYwESc6BdE8o75kZ2jw_wSB4KIA_uEgUIEZ5CBG9jVHAzuIvVkKd4u-Orq_dnHFessOTJg2UXwNjkDi551yToHtvUu7NASupTF1id3SQctgL0hGr2l-U5a_YzLRuFp9mgEG_DZ4TzOvrxdfe7e5esP5xfd2To3pahiPopyVHWlBjlAaVpjsCmhFqIHzg1C3yCXbdsOPRTj0ChZYy-LRkqoVNkmgzzO3uxzd3O_xcGgS_Ot3k20helWeyD9t-Joo7_5G91WUhS1SgEvDwGT_z5jiHpL6Y-sBYd-DlooIXmlRLXMevEPeu3nyaXnLVRqp-Z8oV7vKTP5ECYc75fhhV4610vn-tB5wl_t8Q25AX7Q_-k_PV-vVQ</recordid><startdate>20220927</startdate><enddate>20220927</enddate><creator>Zalegh, Imane</creator><creator>Bourhia, Mohammed</creator><creator>Zerouali, Khalid</creator><creator>Katfy, Khalid</creator><creator>Nayme, Kaotar</creator><creator>Khallouki, Farid</creator><creator>Benzaarate, Ihssane</creator><creator>Mohammad Salamatullah, Ahmad</creator><creator>Alzahrani, Abdulhakeem</creator><creator>Nafidi, Hiba-Allah</creator><creator>Akssira, Mohamed</creator><creator>Ait Mhand, Rajaa</creator><general>Hindawi</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4997-2348</orcidid><orcidid>https://orcid.org/0000-0003-3707-8461</orcidid><orcidid>https://orcid.org/0000-0001-8867-2837</orcidid><orcidid>https://orcid.org/0000-0003-1473-0867</orcidid><orcidid>https://orcid.org/0000-0003-1685-1400</orcidid><orcidid>https://orcid.org/0000-0003-1390-8248</orcidid><orcidid>https://orcid.org/0000-0002-6103-4269</orcidid></search><sort><creationdate>20220927</creationdate><title>Molecular Characterization of Gene-Mediated Resistance and Susceptibility of ESKAPE Clinical Isolates to Cistus monspeliensis L. and Cistus salviifolius L. Extracts</title><author>Zalegh, Imane ; Bourhia, Mohammed ; Zerouali, Khalid ; Katfy, Khalid ; Nayme, Kaotar ; Khallouki, Farid ; Benzaarate, Ihssane ; Mohammad Salamatullah, Ahmad ; Alzahrani, Abdulhakeem ; Nafidi, Hiba-Allah ; Akssira, Mohamed ; Ait Mhand, Rajaa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c425t-f24f7657d3da4c9cce84a622ba11ceab8e13999dba0fd8736eb30833a57494c93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Acetic acid</topic><topic>Antibacterial activity</topic><topic>Antibacterial agents</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Bacteria</topic><topic>Bacterial infections</topic><topic>Biological activity</topic><topic>Cistus monspeliensis</topic><topic>Cistus salviifolius</topic><topic>Clinical isolates</topic><topic>Developing countries</topic><topic>Drug resistance</topic><topic>Enterococcus faecium</topic><topic>Ethyl acetate</topic><topic>Genes</topic><topic>Laboratories</topic><topic>LDCs</topic><topic>Methicillin</topic><topic>Minimum inhibitory concentration</topic><topic>Multidrug resistance</topic><topic>Nosocomial infections</topic><topic>Phytochemicals</topic><topic>Sesquiterpenes</topic><topic>Staphylococcus aureus</topic><topic>Strains (organisms)</topic><topic>Vancomycin</topic><topic>Viridiflorol</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zalegh, Imane</creatorcontrib><creatorcontrib>Bourhia, Mohammed</creatorcontrib><creatorcontrib>Zerouali, Khalid</creatorcontrib><creatorcontrib>Katfy, Khalid</creatorcontrib><creatorcontrib>Nayme, Kaotar</creatorcontrib><creatorcontrib>Khallouki, Farid</creatorcontrib><creatorcontrib>Benzaarate, Ihssane</creatorcontrib><creatorcontrib>Mohammad Salamatullah, Ahmad</creatorcontrib><creatorcontrib>Alzahrani, Abdulhakeem</creatorcontrib><creatorcontrib>Nafidi, Hiba-Allah</creatorcontrib><creatorcontrib>Akssira, Mohamed</creatorcontrib><creatorcontrib>Ait Mhand, Rajaa</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Evidence-based complementary and alternative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zalegh, Imane</au><au>Bourhia, Mohammed</au><au>Zerouali, Khalid</au><au>Katfy, Khalid</au><au>Nayme, Kaotar</au><au>Khallouki, Farid</au><au>Benzaarate, Ihssane</au><au>Mohammad Salamatullah, Ahmad</au><au>Alzahrani, Abdulhakeem</au><au>Nafidi, Hiba-Allah</au><au>Akssira, Mohamed</au><au>Ait Mhand, Rajaa</au><au>Ramanathan, Srinivasan</au><au>Srinivasan Ramanathan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular Characterization of Gene-Mediated Resistance and Susceptibility of ESKAPE Clinical Isolates to Cistus monspeliensis L. and Cistus salviifolius L. Extracts</atitle><jtitle>Evidence-based complementary and alternative medicine</jtitle><date>2022-09-27</date><risdate>2022</risdate><volume>2022</volume><spage>1</spage><epage>16</epage><pages>1-16</pages><issn>1741-427X</issn><eissn>1741-4288</eissn><abstract>Background. Multidrug resistance (MDR) and extensively drug-resistant (XDR) are now the biggest threats to human beings. Alternative antimicrobial regimens to conventional antibiotic paradigms are extensively searched. Although Cistus extracts have long been used for infections in traditional folk medicines around the world, their efficacy against resistant bacteria still needs to be elucidated. We aim to investigate the antibiotic susceptibility profiles of clinical strains Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter cloacae (acronym “ESKAPE”), and their resistance mechanisms by PCR, as well as their sensitivity to C. monspeliensis (CM) and C. salviifolius (CS) methanol extracts and their fractions. Methods. Antibiotic susceptibility profile and resistance mechanism were done by antibiogram and PCR. Fractions of CM and CS were obtained using maceration and Soxhlet; their antibacterial activities were evaluated by determining inhibition zone diameter (IZD), minimum inhibitory concentration (MIC), and minimum bactericidal concentration (MBC). Results. Results revealed that all strains were XDR except S. aureus, which was MDR. The PCR indicates the presence of gene-mediated resistance (blaCTX-M, blaSHV, blaOXA-48, blaNDM, blaOXA-51, blaOXA-58, blaIMP, blaVIM, and blamecA). Also, maceration was slightly better for bioactivity preservation. Overall, the extracts of CM (IZD = 20 mm, MIC = 0.01 mg/mL) were more active than those of CS. All extracts inhibited MRSA (methicillin-resistant Staphylococcus aureus) and ERV (Enterococcus faecium Vancomycin-Resistant) with interesting MICs. The ethyl acetate fraction manifested great efficacy against all strains. Monoterpene hydrocarbons and sesquiterpenes oxygenated were the chemical classes of compounds dominating the analyzed fractions. Viridiflorol was the major compound in ethyl acetate fractions of 59.84% and 70.77% for CM and CS, respectively. Conclusions. The superior activity of extracts to conventional antibiotics was seen for the first time in the pathogens group, and their bactericidal effect could be a promising alternative for developing clinical antibacterial agents against MDR and XDR ESKAPE bacteria.</abstract><cop>New York</cop><pub>Hindawi</pub><doi>10.1155/2022/7467279</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0003-4997-2348</orcidid><orcidid>https://orcid.org/0000-0003-3707-8461</orcidid><orcidid>https://orcid.org/0000-0001-8867-2837</orcidid><orcidid>https://orcid.org/0000-0003-1473-0867</orcidid><orcidid>https://orcid.org/0000-0003-1685-1400</orcidid><orcidid>https://orcid.org/0000-0003-1390-8248</orcidid><orcidid>https://orcid.org/0000-0002-6103-4269</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1741-427X
ispartof Evidence-based complementary and alternative medicine, 2022-09, Vol.2022, p.1-16
issn 1741-427X
1741-4288
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9532067
source PubMed Central Open Access; Wiley-Blackwell Open Access Titles; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Acetic acid
Antibacterial activity
Antibacterial agents
Antibiotics
Antimicrobial agents
Bacteria
Bacterial infections
Biological activity
Cistus monspeliensis
Cistus salviifolius
Clinical isolates
Developing countries
Drug resistance
Enterococcus faecium
Ethyl acetate
Genes
Laboratories
LDCs
Methicillin
Minimum inhibitory concentration
Multidrug resistance
Nosocomial infections
Phytochemicals
Sesquiterpenes
Staphylococcus aureus
Strains (organisms)
Vancomycin
Viridiflorol
title Molecular Characterization of Gene-Mediated Resistance and Susceptibility of ESKAPE Clinical Isolates to Cistus monspeliensis L. and Cistus salviifolius L. Extracts
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T21%3A14%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20Characterization%20of%20Gene-Mediated%20Resistance%20and%20Susceptibility%20of%20ESKAPE%20Clinical%20Isolates%20to%20Cistus%20monspeliensis%20L.%20and%20Cistus%20salviifolius%20L.%20Extracts&rft.jtitle=Evidence-based%20complementary%20and%20alternative%20medicine&rft.au=Zalegh,%20Imane&rft.date=2022-09-27&rft.volume=2022&rft.spage=1&rft.epage=16&rft.pages=1-16&rft.issn=1741-427X&rft.eissn=1741-4288&rft_id=info:doi/10.1155/2022/7467279&rft_dat=%3Cproquest_pubme%3E2722976119%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2722976119&rft_id=info:pmid/&rfr_iscdi=true